Use of LDH and autoimmune side effects to predict response to ipilimumab treatment

被引：44
作者：
Dick, J. [1 ]
Lang, N. [1 ]
Slynko, A. [2 ]
Kopp-Schneider, A. [2 ]
Schulz, C. [1 ]
Dimitrakopoulou-Strauss, A. [3 ]
Enk, A. H. [1 ]
Hassel, J. C. [1 ]
机构：
[1] Univ Heidelberg Hosp, Dept Dermatol Natl Ctr Tumor Dis, Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[3] German Canc Res Ctr Heidelberg, Clin Cooperat Unit Nucl Med, Heidelberg, Germany
来源：
IMMUNOTHERAPY | 2016年 / 8卷 / 09期
关键词：
autoimmune side effects; ipilimumab; LDH; melanoma; EXPANDED ACCESS PROGRAM; METASTATIC MELANOMA; CTLA-4; BLOCKADE; CLINICAL-RESPONSE; SURVIVAL; EXPERIENCE; LYMPHOCYTE; THERAPY; IL-2;
D O I：
10.2217/imt-2016-0083
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background: Ipilimumab is a cytotoxic T-lymphocyte antigen-4 antibody that enhances T-cell activity and proliferation. Methods: In a retrospective analysis of 86 patients the clinical benefits of ipilimumab treatment were correlated with laboratory and clinical data. Results: A lactate dehydrogenase (LDH) value within the normal range before the start of therapy was significantly correlated with better OS (p <= 0.009). An increase in LDH level after two cycles was indicative of a poor outcome, and was significantly negatively correlated with treatment response and overall survival and progression-free survival. 42% of all patients suffered from autoimmune toxicity (CTCAE grades 2-4). The occurrence of autoimmune toxicity clearly correlated with clinical benefit. Conclusion: Changes in LDH level and side effects correlate with response to therapy and survival.
引用
收藏
页码：1033 / 1044
页数：12
相关论文
共 26 条
  • [1] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE
    ANDERSON, JR
    CAIN, KC
    GELBER, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 710 - 719
  • [2] Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
    Ascierto, Paolo A.
    Simeone, Ester
    Sileni, Vanna Chiarion
    Pigozzo, Jacopo
    Maio, Michele
    Altomonte, Maresa
    Del Vecchio, Michele
    Di Guardo, Lorenza
    Marchetti, Paolo
    Ridolfi, Ruggero
    Cognetti, Francesco
    Testori, Alessandro
    Bernengo, Maria Grazia
    Guida, Michele
    Marconcini, Riccardo
    Mandala, Mario
    Cimminiello, Carolina
    Rinaldi, Gaetana
    Aglietta, Massimo
    Queirolo, Paola
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [3] Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types
    Ascierto, Paolo A.
    Kalos, Michael
    Schaer, David A.
    Callahan, Margaret K.
    Wolchok, Jedd D.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (05) : 1009 - 1020
  • [4] Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    Attia, P
    Phan, GQ
    Maker, AV
    Robinson, MR
    Quezado, MM
    Yang, JC
    Sherry, RM
    Topalian, SL
    Kammula, US
    Royal, RE
    Restifo, NP
    Haworth, LR
    Levy, C
    Mavroukakis, SA
    Nichol, G
    Yellin, MJ
    Rosenberg, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6043 - 6053
  • [5] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [6] Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
    Delyon, J.
    Mateus, C.
    Lefeuvre, D.
    Lanoy, E.
    Zitvogel, L.
    Chaput, N.
    Roy, S.
    Eggermont, A. M. M.
    Routier, E.
    Robert, C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (06) : 1697 - 1703
  • [7] Eigentler TK, 2014, J IMMUNOTHER, V37, P374, DOI 10.1097/CJI.0000000000000046
  • [8] Melanoma Survival Disadvantage in Young, Non-Hispanic White Males Compared With Females
    Gamba, Christina S.
    Clarke, Christina A.
    Keegan, Theresa H. M.
    Tao, Li
    Swetter, Susan M.
    [J]. JAMA DERMATOLOGY, 2013, 149 (08) : 912 - 920
  • [9] Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
    Halama, Niels
    Michel, Sara
    Kloor, Matthias
    Zoernig, Inka
    Benner, Axel
    Spille, Anna
    Pommerencke, Thora
    Doeberitz, Magnus von Knebel
    Folprecht, Gunnar
    Luber, Birgit
    Feyen, Nadine
    Martens, Uwe M.
    Beckhove, Philipp
    Gnjatic, Sacha
    Schirmacher, Peter
    Herpel, Esther
    Weitz, Juergen
    Grabe, Niels
    Jaeger, Dirk
    [J]. CANCER RESEARCH, 2011, 71 (17) : 5670 - 5677
  • [10] Hannani D, 2015, CELL RES, V25, P399, DOI [10.1038/cr.2015.3, 10.1038/cr.2015.28]
123